Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid** is a synthetic small molecule belonging to the benzanilide class of organic compounds. It features a phthalic acid backbone linked via an ether bond to a phenyl ring, which is further substituted with a (3-nitrobenzoyl)amino group. This compound has been studied as an experimental inhibitor of glycogen phosphorylase, muscle form—a key enzyme involved in glycogen breakdown. There are no approved indications or clinical trials for this compound; it remains at the experimental research stage[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid.